Priority Review Granted to Hep C Drug Simeprevir | Hepatitis Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Menu Search
Previous

Study Shows Simeprevir Improves Hep C Therapy

Back to News Homepage
Next

Disclosing Hep C Status in the Workplace

Priority Review Granted to Hep C Drug Simeprevir

The Editors at Hepatitis Central
May 15, 2013

Print this page

Due to positive results from three Phase III trials, the FDA has granted a priority review to simeprevir, a Hepatitis C protease inhibitor that is administered with interferon and ribavirin therapy.

Simeprevir Given Priority Review Status By FDA For Hepatitis C Treatment

With stunning results in Phase III clinical trials, the hepatitis C drug is now on a fast track for FDA approval.

By Jonathan Weiss | May 13, 2013

Following previous hepatitis C treatments that were given expedited U.S. Food and Drug Administration (FDA) approval processes and breakthrough status designations, Janssen and Medivir’s jointly developed simeprevir has been given priority review status by the FDA, Medivir announced today. Priority reviews have historically reduced the approval process time by half and are given to drugs that have evidence of increased effectiveness, prevention, or diagnoses of a disease.

Continue reading this entire article:
http://www.medicaldaily.com/articles/15454/20130513/simeprevir-fda-hepatitis-c-hepatitis-c-drug.htm

14 Comments
Share
Share
Previous

Study Shows Simeprevir Improves Hep C Therapy

Back to News Homepage
Next

Disclosing Hep C Status in the Workplace

Requirements for using and reposting articles

Comments

HepatitisCentral.com provides information regarding hepatitis and liver disease. Comments are available to the community in order to discuss these topics and obtain answers to questions through community members. The Editors at HepatitisCentral.com will not be responding to questions or comments posed in article comments.

14 Comments

  • Brian Dusel says:

    Just another Interferon based treatment! And since this is another protease inhibitor this treatment is useless for those that tried and failed the hugely disappointing & over rated Incivek.

    • zenseekercu says:

      Yes, I followed the required treatment for Incivek to a ‘T’. I showed an initial response (which I also did with Pegasys and Ribavirin before), but relapsed as soon as I discontinued the drugs. I’m holding out for an all-oral therapy, if I live that long. The FDA can be pretty slow. I am type 1.

      • Wil James says:

        I am type 1 also. I did the combination therapy, pegasys and ribiviran. Relapsed as soon as I finished treatment. I also did pegasys by its self. Same result. Is there anything in the wings?

        • zenseekercu says:

          Sorry to be so long in getting back to you. I just finished a 3-month long oral treatment of Solvaldi/Olysio. No virus found~ but of course, I have to remain that way for 6 months to be considered “cured”. The treatment is quite expensive ($150,000), but I would recommend trying it if your insurance will pay for it, or you can get financial assistance (ask your provider about that). There were hardly any side effects, just mild headache occasionally, and some tiredness. It was a piece of cake. Message me on Twitter or Google+ if you have any questions.

  • Skeptic says:

    Why don’t the clinicians at FDA fast track some of the products in early stage development that have achieved there safety data. Perhaps an FDA’er would like a few doses of Interferon to see what you go through for “increased effectiveness.” These treatments are costly and offer little in terms of efficacy.

  • Kevin says:

    I had Hep C Genotype 4. I took Bristol Myers Squibb’s three all oral drugs. I took them for 12 weeks and I was undetectable by week 4. I stopped the drugs on April 23, 2013 and hopefully the virus will not return. I go for my 4-week-off-the-drugs blood test next week. Hopefully, the virus hasn’t returned. If it hasn’t returned by 8th week off the drugs then I will be considered cured. The only side-effect from the drugs was a slight headache and that was the worst of it. Even though 60 people before me have remained virus-free for a year, the FDA is no where near ready to approve the BMS drugs, it makes no sense.

    • jim says:

      pls Mr. kevin can you name all oral drugs of Bristol Myers Squibb’s ? i need to buy them too. thank you so much

  • Hi Kevin, pls how do I get the drug? I have type 4 and NHS refused to treat me with Teleprevir. Pls kindly help me. My email is thetechm@yahoo.co.uk or pls call me on 07877988240. Pls help me

  • How did you get the Bristol Mayer Squibbs medication for type 4

  • Apathetic&tired says:

    Blah, Blah, Blah! Anything the FDA does takes at least 10 years unless the manufacturer pays them up front!

  • guest says:

    what after i have
    HCV 1 I am Egyptian I talk Pegases and interferon for 1 year, within 5 month
    from the treatment the result was indictable
    , i complete the 1 year course,
    and after 6 months from finishing the course again PCR result deceted, i don’t
    know I start this killing course again even with this protease medication, or I
    wait may be I can leave more rather than taking this killing courses, I need advice???

    Note my test result
    IL28B RS 12979860 genotype I found
    my type C/T

Leave a Reply

Your email address will not be published. Required fields are marked *